Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for Type 2 diabetes--should it be now?

K Borch-Johnsen1, T Lauritzen, C Glümer

  • 1Steno Diabetes Centre, Gentofte, Denmark.

Diabetic Medicine : a Journal of the British Diabetic Association
|April 5, 2003
PubMed
Summary

Type 2 diabetes does not meet criteria for mass population screening. More research is needed on screening effectiveness and consequences before widespread implementation. Opportunistic screening in high-risk individuals is advised.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of the Copenhagen Disease Management Program for Type 2 Diabetes on Healthcare Utilization.

Journal of diabetes research·2026
Same author

Periodontitis and Diabetes Complications: A Danish Population-Based Study.

Journal of dental research·2024
Same author

Co-occurrence of Periodontitis and Diabetes-Related Complications.

Journal of dental research·2023
Same author

Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trial.

Diabetic medicine : a journal of the British Diabetic Association·2020

Area of Science:

  • Endocrinology
  • Public Health
  • Screening Criteria Evaluation

Background:

  • Increasing prevalence of Type 2 diabetes necessitates evaluation of screening strategies.
  • Global recommendations for Type 2 diabetes screening exist, prompting a review of its suitability.
  • Understanding the disease's characteristics is crucial for determining appropriate screening approaches.

Purpose of the Study:

  • To assess if Type 2 diabetes meets the World Health Organization's (WHO) established criteria for screening.
  • To review existing literature on screening strategies and diagnostic tests for Type 2 diabetes.
  • To evaluate the psychosocial and health economic implications of screening for Type 2 diabetes.

Main Methods:

  • Comprehensive literature search using MedLine, PubMed, NIDDK, Cochrane Library, and CINAHL.

Related Experiment Videos

  • MeSH terms 'non-insulin-dependent-diabetes-mellitus' and 'mass screening' were utilized.
  • Evaluation of psychosocial consequences incorporated studies from other chronic diseases.

    • Main Results:

    • No randomized controlled trials specifically evaluating screening for Type 2 diabetes were identified, precluding meta-analysis.
    • Literature review indicates that Type 2 diabetes does not currently fulfill WHO screening criteria.
    • Data on the positive and negative effects of screening, as well as psychosocial and health economic consequences, are limited.

    Conclusions:

    • Population-based mass screening for Type 2 diabetes is not currently supported by evidence meeting WHO criteria.
    • Further systematic screening and intervention trials are recommended.
    • Intensified case finding and opportunistic screening in high-risk groups are advised in the interim.